Suchergebnisse - "Liu, Qin"

PubPharm (46)

1

Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells

enthalten in: Journal for immunotherapy of cancer | 2024

von Yankelevich, M. | Thakur, A. | Modak, S. | +12

UpdateOf: Res Sq. 2023 Nov 09;:. - PMID 37986911

2

Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis

enthalten in: Cell death & disease | 2023

von Zhang, S. | Liu, Q. | Chang, M. | +4

3

Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccination

enthalten in: Cancer science | 2021

von Chu, Y. | Li, R. | Qian, L. | +8

4

Synthesis and biological evaluation of zwitterionic half-sandwich Rhodium(III) and Ruthenium(II) organometallic complexes

enthalten in: Bioorganic chemistry | 2021

von Guo, L. | Hu, X. | Yang, Y. | +4

5

Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance

enthalten in: Cancer research | 2021

von Liu, J. | Rebecca, V. | Kossenkov, A. | +45

6

A Novel Inhibitor of HSP70 Induces Mitochondrial Toxicity and Immune Cell Recruitment in Tumors

enthalten in: Cancer research | 2020

von Barnoud, T. | Leung, J. | Leu, J. | +18

7

Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway

enthalten in: Acta pharmaceutica (Zagreb, Croatia) | 2020

von Wang, N. | Feng, T. | Liu, X. | +1

8

Mushroom extracts and compounds with suppressive action on breast cancer : evidence from studies using cultured cancer cells, tumor-bearing animals, and clinical trials

enthalten in: Applied microbiology and biotechnology | 2020

von Wong, J. | Ng, T. | Chan, H. | +15

9

Prominent Enhancement of Cisplatin Efficacy with Optimized Methoxy Poly(ethylene glycol)-Polycaprolactone Block Copolymeric Nanoparticles

enthalten in: Journal of biomedical nanotechnology | 2020

von Yen, Y. | Wang, X. | Zhang, H. | +10

10

EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition

enthalten in: Cancer cell | 2020

von Karakashev, S. | Fukumoto, T. | Zhao, B. | +11

CommentIn: Cancer Cell. 2020 Feb 10;37(2):139-140. - PMID 32049041

1
2
3
4
5
Nächster »
[5]